Dr. Lal PathLabs Ltd (BOM:539524)
₹ 3032.8 -65.45 (-2.11%) Market Cap: 252.57 Bil Enterprise Value: 242.94 Bil PE Ratio: 63.01 PB Ratio: 12.63 GF Score: 99/100

Q2 2022 Dr. Lal PathLabs Ltd Earnings Call Transcript

Oct 27, 2021 / 02:30AM GMT
Release Date Price: ₹3513.55 (-1.14%)
Operator

Good morning, ladies and gentlemen. Welcome to the Dr. Lal PathLabs Q2 FY '22 Earnings Conference Call. (Operator Instructions)

Please note that this conference is being recorded. I now hand the conference over to Mr. Siddharth Rangnekar of CDR India. Thank you, and over to you, sir.

Siddharth Rangnekar
Citigate Dewe Rogerson Communications Private Limited - IR Manager

Thank you. Good morning, everyone, and welcome to Dr. Lal PathLabs Quarter 2 and H1 FY '22 Earnings Conference Call. Today, we are joined by senior members of the management team, including Honorary Brigadier, Dr. Arvind Lal, Executive Chairman; Dr. Om Prakash Manchanda, Managing Director; Mr. Bharath Uppiliappan, CEO; and Mr. Ved Prakash Goel, CFO; along with Mr. Rajat Kalra, Company Secretary and Head of Investor Relations. Also joining us today is Dr. Sanjay Arora, Founder of Suburban Diagnostics.

Let me lead our standard disclaimer over here. Some of the statements made on today's call could be forward-looking in nature, and the actual results could vary from these forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot